Previous 10 | Next 10 |
LUND, SE / ACCESSWIRE / December 10, 2021 / BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV) , a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, today announced that the Center for D...
CASI PHARMACEUTICALS AND BIOINVENT ANNOUNCE CTA APPROVAL FOR CLINICAL STUDY OF BI-1206 IN NHL IN CHINA ~ NMPA approved BI-1206 CTA a novel anti-FcγRIIB ~~ Trials Expected to Enroll Patients starting in 1H 2022 PR Newswire ROCKVILLE, Md. and BEIJING ...
Rockville, Maryland-based CASI Pharmaceuticals (NASDAQ:CASI) has added ~11.6% in the pre-market on below-average volume after its CEO Wei-Wu He disclosed the purchase of 400K company shares. About 456.7K CASI (CASI) shares have changed hands so far, compared to the 65-day average vo...
CASI Pharmaceuticals To Present At Jefferies London Healthcare Conference PR Newswire ROCKVILLE, Md. , and BEIJING , Nov. 15, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and comme...
CASI Pharmaceuticals, Inc. (CASI) Q3 2021 Earnings Conference Call November 12, 2021, 08:00 ET Company Participants Jacob Moshel - IR Wei-Wu He - Chairman & CEO Alexander Zukiwski - Chief Medical Officer Wong Hu - Former COO, General Counsel & Secretary Conference Call Participants Le...
CASI Pharmaceuticals (NASDAQ:CASI): Q3 GAAP EPS of -$0.07 misses by $0.01. Revenue of $8.11M (+91.3% Y/Y) beats by $0.58M. Press Release As of September 30, 2021, CASI had cash and cash equivalents of $53.1M compared to $57.1M as of December 31, 2020. For further details see: CASI Pharm...
CASI Pharmaceuticals Announces Third Quarter 2021 Financial Results -EVOMELA Third Quarter 2021 Revenue Continues Strong Upward Trend - - Additional Positive Clinical Data on BI-1206 - - Partner Juventas completed Series C financing round RMB410 million (approximately $6...
CASI Pharmaceuticals (NASDAQ:CASI) is scheduled to announce Q3 earnings results on Friday, November 12th, before market open. The consensus EPS Estimate is -$0.06 (+57.1% Y/Y) and the consensus Revenue Estimate is $7.53M (+77.6% Y/Y). Over the last 3 months, EPS estimates have seen 1 upward r...
AZN, BKKT, BKSY, BPTH, CAAS, CASI, OTCQX:CCHWF, CGEN, OTCQX:DTEGF, EMAN, GP, OTCPK:HNHAF, HYZN, ITRM, MIR, MOTS, NGD, NXTD, PX, SOHO, SPB, STRR, OTCPK:TOSBF, VERO, OTCPK:VITFF, VIVO For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earn...
CASI Pharmaceuticals Partner, BioInvent, To Present Further Positive Clinical Data On BI-1206 At ASH 2021 ~ BI-1206 restores rituximab activity in relapsed or refractory patients ~~ Demonstrates ORR 50%, DCR 58%, with complete responses lasting beyond 18 and 24 months PR...
News, Short Squeeze, Breakout and More Instantly...
CASI Pharmaceuticals Inc. Company Name:
CASI Stock Symbol:
NASDAQ Market:
CASI Pharmaceuticals Inc. Website:
2024-07-17 13:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
CASI Pharmaceuticals announces appointment of Daniel Lang, MD as CFO and SVP PR Newswire BEIJING , July 8, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman incorporated biopharmaceutical company focused on developing and commercializing in...
A look at the top 10 most actives in the United States Faraday Future Intelligent Electric Inc. (FFIE) rose 30.9% to $0.6 on volume of 558,931,853 shares NVIDIA Corporation (NVDA) fell 1.9% to $123.99 on volume of 249,243,816 shares Assure Holdings Corp. (IONM) rose 82.8% to $0.424 on vol...